查找与器官及解剖学疾病相关的、专注于疾病的小分子,用于转化研究、模型选择及药物发现工作流程。利用本页面浏览按组织特异性或系统级疾病生物学分类的化合物。
器官/解剖疾病
按类别选购
神经系统疾病(DOID:863) nervous system disease (DOID:863)
1,388胃肠道系统疾病(DOID:77) gastrointestinal system disease (DOID:77)
3,892心血管系统疾病(DOID:1287) cardiovascular system disease (DOID:1287)
2,720免疫系统疾病(DOID:2914) immune system disease (DOID:2914)
986肌肉骨骼系统疾病(DOID:17) musculoskeletal system disease (DOID:17)
759内分泌系统疾病(DOID:28) endocrine system disease (DOID:28)
3,795泌尿系统疾病(DOID:18) urinary system disease (DOID:18)
123呼吸系统疾病(DOID:1579) respiratory system disease (DOID:1579)
4,223生殖系统疾病(DOID:15) reproductive system disease (DOID:15)
373胸外科疾病(DOID:0060118) thoracic disease (DOID:0060118)
1,268皮肤系统疾病(DOID:16) integumentary system disease (DOID:16)
1,919造血系统疾病(DOID:74) hematopoietic system disease (DOID:74)
725产品列表
-
1-[4-[4-[2-[4-chloro-3-(diethylsulfamoyl)anilino]pyrimidin-4-yl]pyridin-2-yl]phenyl]-3-methylurea化合物 CID: 71458575Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: C608659查看产品价格与包装
技术标识符
- IUPAC名称
- 1-[4-[4-[2-[4-chloro-3-(diethylsulfamoyl)anilino]pyrimidin-4-yl]pyridin-2-yl]phenyl]-3-methylurea
- SMILES
- CNC(=O)Nc1ccc(cc1)c1nccc(c1)c1ccnc(n1)Nc1ccc(c(c1)S(=O)(=O)N(CC)CC)Cl
- InChIKey
- RZFJBSIAXYEPBX-UHFFFAOYSA-N
- InChI
- 1S/C27H28ClN7O3S/c1-4-35(5-2)39(37,38)25-17-21(10-11-22(25)28)32-26-31-15-13-23(34-26)19-12-14-30-24(16-19)18-6-8-20(9-7-18)33-27(36)29-3/h6-17H,4-5H2,1-3H3,(H2,29,33,36)(H,31,32,34)
-
1-[[5-chloro-2-(trifluoromethyl)phenyl]methyl]-7-(2-piperazin-1-ylpyridin-4-yl)-3,4-dihydro-2H-pyrido[2,3-b]pyrazine化合物 CID: 46871653Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: C609341查看产品价格与包装
技术标识符
- IUPAC名称
- 1-[[5-chloro-2-(trifluoromethyl)phenyl]methyl]-7-(2-piperazin-1-ylpyridin-4-yl)-3,4-dihydro-2H-pyrido[2,3-b]pyrazine
- SMILES
- Clc1ccc(c(c1)CN1CCNc2c1cc(cn2)c1ccnc(c1)N1CCNCC1)C(F)(F)F
- InChIKey
- AHZCYZMNFBGXAC-UHFFFAOYSA-N
- InChI
- 1S/C24H24ClF3N6/c25-19-1-2-20(24(26,27)28)18(11-19)15-34-10-7-31-23-21(34)12-17(14-32-23)16-3-4-30-22(13-16)33-8-5-29-6-9-33/h1-4,11-14,29H,5-10,15H2,(H,31,32)
-
11,13-diamino-5-(4-methylphenyl)-8-thia-3,5,10,12-tetraazatricyclo[7.4.0.0^{2,7}]trideca-1(13),2(7),3,9,11-pentaen-6-one化合物 CID: 46866191Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: D608980查看产品价格与包装
技术标识符
- IUPAC名称
- 11,13-diamino-5-(4-methylphenyl)-8-thia-3,5,10,12-tetraazatricyclo[7.4.0.0^{2,7}]trideca-1(13),2(7),3,9,11-pentaen-6-one
- SMILES
- Cc1ccc(cc1)n1cnc2c(c1=O)sc1c2c(N)nc(n1)N
- InChIKey
- NGINYBBVZOLUBV-UHFFFAOYSA-N
- InChI
- 1S/C15H12N6OS/c1-7-2-4-8(5-3-7)21-6-18-10-9-12(16)19-15(17)20-13(9)23-11(10)14(21)22/h2-6H,1H3,(H4,16,17,19,20)
-
1-[4-[methyl-[2-(3-sulfamoylanilino)pyrimidin-4-yl]amino]phenyl]-3-[4-(trifluoromethoxy)phenyl]urea化合物 CID: 5329829Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: M611956查看产品价格与包装
技术标识符
- SMILES
- O=C(Nc1ccc(cc1)OC(F)(F)F)Nc1ccc(cc1)N(c1ccnc(n1)Nc1cccc(c1)S(=O)(=O)N)C
- InChIKey
- SNRUTMWCDZHKKM-UHFFFAOYSA-N
- InChI
- 1S/C25H22F3N7O4S/c1-35(22-13-14-30-23(34-22)31-18-3-2-4-21(15-18)40(29,37)38)19-9-5-16(6-10-19)32-24(36)33-17-7-11-20(12-8-17)39-25(26,27)28/h2-15H,1H3,(H2,29,37,38)(H,30,31,34)(H2,32,33,36)
-
1-[5-[6-(2,6-dimethyl-4-pentan-3-yloxyphenyl)-2-pyrazin-2-ylpyrimidin-4-yl]-1,3-thiazol-2-yl]-3-methylurea化合物 CID: 58688690Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: D609099查看产品价格与包装
技术标识符
- IUPAC名称
- 1-[5-[6-(2,6-dimethyl-4-pentan-3-yloxyphenyl)-2-pyrazin-2-ylpyrimidin-4-yl]-1,3-thiazol-2-yl]-3-methylurea
- SMILES
- CNC(=O)Nc1ncc(s1)c1nc(nc(c1)c1c(C)cc(cc1C)OC(CC)CC)c1nccnc1
- InChIKey
- RYXLLTGGHCFCFK-UHFFFAOYSA-N
- InChI
- 1S/C26H29N7O2S/c1-6-17(7-2)35-18-10-15(3)23(16(4)11-18)20-12-19(22-14-30-26(36-22)33-25(34)27-5)31-24(32-20)21-13-28-8-9-29-21/h8-14,17H,6-7H2,1-5H3,(H2,27,30,33,34)
-
1-[6-(5-methoxypyridin-3-yl)-1,3-benzothiazol-2-yl]-3-[2-(1-propylimidazol-4-yl)ethyl]urea化合物 CID: 73659199Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: M608958查看产品价格与包装
技术标识符
- IUPAC名称
- 1-[6-(5-methoxypyridin-3-yl)-1,3-benzothiazol-2-yl]-3-[2-(1-propylimidazol-4-yl)ethyl]urea
- SMILES
- CCCn1cnc(c1)CCNC(=O)Nc1nc2c(s1)cc(cc2)c1cncc(c1)OC
- InChIKey
- VYPWROGLWNYKDD-UHFFFAOYSA-N
- InChI
- 1S/C22H24N6O2S/c1-3-8-28-13-17(25-14-28)6-7-24-21(29)27-22-26-19-5-4-15(10-20(19)31-22)16-9-18(30-2)12-23-11-16/h4-5,9-14H,3,6-8H2,1-2H3,(H2,24,26,27,29)
-
13-(dimethylamino)-5-(2-fluoro-4-methoxyphenyl)-8-thia-3,5,10,12-tetraazatricyclo[7.4.0.0^{2,7}]trideca-1(13),2(7),3,9,11-pentaen-6-one化合物 CID: 16725048Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: D609484查看产品价格与包装
技术标识符
- IUPAC名称
- 13-(dimethylamino)-5-(2-fluoro-4-methoxyphenyl)-8-thia-3,5,10,12-tetraazatricyclo[7.4.0.0^{2,7}]trideca-1(13),2(7),3,9,11-pentaen-6-one
- SMILES
- COc1ccc(c(c1)F)n1cnc2c(c1=O)sc1c2c(ncn1)N(C)C
- InChIKey
- XUSKBQJCEPMVBM-UHFFFAOYSA-N
- InChI
- 1S/C17H14FN5O2S/c1-22(2)15-12-13-14(26-16(12)20-7-19-15)17(24)23(8-21-13)11-5-4-9(25-3)6-10(11)18/h4-8H,1-3H3
-
2,4-Difluoro-N-(2-methoxy-5-(3-(5-(2-(4-methylpiperazin-1-yl)ethyl)-1,3,4-oxadiazol-2-yl)imidazo[1,2-a]pyridin-6-yl)pyridin-3-yl)benzenesulfonamide化合物 CID: 145996540Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: D608737查看产品价格与包装
技术标识符
- IUPAC名称
- 2,4-Difluoro-N-(2-methoxy-5-(3-(5-(2-(4-methylpiperazin-1-yl)ethyl)-1,3,4-oxadiazol-2-yl)imidazo[1,2-a]pyridin-6-yl)pyridin-3-yl)benzenesulfonamide
- SMILES
- COc1ncc(cc1NS(=O)(=O)c1ccc(cc1F)F)c1ccc2n(c1)c(cn2)c1nnc(o1)CCN1CCN(CC1)C
- InChIKey
- LSPJWTULWKYRTQ-UHFFFAOYSA-N
- InChI
- 1S/C28H28F2N8O4S/c1-36-9-11-37(12-10-36)8-7-26-33-34-28(42-26)23-16-31-25-6-3-18(17-38(23)25)19-13-22(27(41-2)32-15-19)35-43(39,40)24-5-4-20(29)14-21(24)30/h3-6,13-17,35H,7-12H2,1-2H3
-
2,2,2-TEMPSCAS: 353234-67-0 化合物 CID: 11362035Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: T607095查看产品价格与包装
技术标识符
- IUPAC名称
- 2,2,2-trifluoro-N-(3-pentan-2-yloxyphenyl)-N-(pyridin-3-ylmethyl)ethanesulfonamide
- SMILES
- CCCC(Oc1cccc(c1)N(S(=O)(=O)CC(F)(F)F)Cc1cccnc1)C
- InChIKey
- ICFXZBZASBXILF-UHFFFAOYSA-N
- InChI
- 1S/C19H23F3N2O3S/c1-3-6-15(2)27-18-9-4-8-17(11-18)24(13-16-7-5-10-23-12-16)28(25,26)14-19(20,21)22/h4-5,7-12,15H,3,6,13-14H2,1-2H3
-
2,6-dichloro-4-[2-methyl-1-(1-methylpiperidin-4-yl)imidazo[4,5-c]quinolin-8-yl]phenol化合物 CID: 165368933Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: D609463查看产品价格与包装
技术标识符
- SMILES
- Oc1c(Cl)cc(c2ccc3ncc4nc(C)n(C5CCN(C)CC5)c4c3c2)cc1Cl
- InChIKey
- JEESDVDVWGRNFE-UHFFFAOYSA-N
- InChI
- 1S/C23H22Cl2N4O/c1-13-27-21-12-26-20-4-3-14(15-10-18(24)23(30)19(25)11-15)9-17(20)22(21)29(13)16-5-7-28(2)8-6-16/h3-4,9-12,16,30H,5-8H2,1-2H3
-
2'-Me-CCPA化合物 CID: 10475082Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: M607125查看产品价格与包装
技术标识符
- IUPAC名称
- (2R,3R,4R,5R)-2-[2-chloro-6-(cyclopentylamino)purin-9-yl]-5-(hydroxymethyl)-3-methyloxolane-3,4-diol
- SMILES
- OC[C@H]1O[C@H]([C@]([C@@H]1O)(C)O)n1cnc2c1nc(Cl)nc2NC1CCCC1
- InChIKey
- MMPAUXMIDJWGFO-ROMFRFKVSA-N
- InChI
- 1S/C16H22ClN5O4/c1-16(25)11(24)9(6-23)26-14(16)22-7-18-10-12(19-8-4-2-3-5-8)20-15(17)21-13(10)22/h7-9,11,14,23-25H,2-6H2,1H3,(H,19,20,21)/t9-,11-,14-,16-/m1/s1
-
2,3-di(thiophen-2-yl)benzo[g]quinoxaline-8-carboxylic acid化合物 CID: 11668217Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。期货 货号: D608705查看产品价格与包装
技术标识符
- IUPAC名称
- 2,3-di(thiophen-2-yl)benzo[g]quinoxaline-8-carboxylic acid
- SMILES
- OC(=O)c1ccc2c(c1)cc1c(c2)nc(c(n1)c1cccs1)c1cccs1
- InChIKey
- GXGUVSXXUOACEX-UHFFFAOYSA-N
- InChI
- 1S/C21H12N2O2S2/c24-21(25)13-6-5-12-10-15-16(11-14(12)9-13)23-20(18-4-2-8-27-18)19(22-15)17-3-1-7-26-17/h1-11H,(H,24,25)
快速发货
现货产品当日发货
技术详情
每个产品页均提供质量和规格信息
多种规格
多种包装规格和价格可选
仅供科研
产品仅供研发使用
常见问题
最后更新:2026年11月5日
器官/解剖疾病下收录了哪些内容?
该分类汇集了注释到与器官/解剖疾病相关靶点和通路的化合物及工具分子。它是快速圈定研究用化合物集的入口,不构成任何治疗建议。
器官/解剖疾病涵盖哪些内容?
器官/解剖疾病是按疾病分类(DOID)下按疾病注释的分类,汇集了跨多个靶点家族、在该领域有相关报道的化合物。
如何为器官/解剖疾病研究挑选化合物?
针对器官/解剖疾病,建议从靶点或通路假设出发,而非从疾病标签出发,随后核实所报道的活性是否在与您体系相关的模型中测得。在确定化合物集之前,请确认效价、选择性和溶解性。所有产品仅供专业研发用途,不得用于人体、动物、诊断或治疗。
如何在器官/解剖疾病下查找特定化合物?
可在器官/解剖疾病中按化合物名称、CAS号或SMILES搜索,也可按对应靶点筛选。未收录的化合物或大包装请联系 compliance@aladdinsci.com。我们仅向经核实的企业、科研机构、高校和政府机构供货。
![1-[4-[4-[2-[4-chloro-3-(diethylsulfamoyl)anilino]pyrimidin-4-yl]pyridin-2-yl]phenyl]-3-methylurea](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/C/6/C608659.png)
![1-[[5-chloro-2-(trifluoromethyl)phenyl]methyl]-7-(2-piperazin-1-ylpyridin-4-yl)-3,4-dihydro-2H-pyrido[2,3-b]pyrazine](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/C/6/C609341.png)
![11,13-diamino-5-(4-methylphenyl)-8-thia-3,5,10,12-tetraazatricyclo[7.4.0.0^{2,7}]trideca-1(13),2(7),3,9,11-pentaen-6-one](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/D/6/D608980.png)
![1-[4-[methyl-[2-(3-sulfamoylanilino)pyrimidin-4-yl]amino]phenyl]-3-[4-(trifluoromethoxy)phenyl]urea](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/M/6/M611956.png)
![1-[5-[6-(2,6-dimethyl-4-pentan-3-yloxyphenyl)-2-pyrazin-2-ylpyrimidin-4-yl]-1,3-thiazol-2-yl]-3-methylurea](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/D/6/D609099.png)
![1-[6-(5-methoxypyridin-3-yl)-1,3-benzothiazol-2-yl]-3-[2-(1-propylimidazol-4-yl)ethyl]urea](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/M/6/M608958.png)
![13-(dimethylamino)-5-(2-fluoro-4-methoxyphenyl)-8-thia-3,5,10,12-tetraazatricyclo[7.4.0.0^{2,7}]trideca-1(13),2(7),3,9,11-pentaen-6-one](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/D/6/D609484.png)
![2,4-Difluoro-N-(2-methoxy-5-(3-(5-(2-(4-methylpiperazin-1-yl)ethyl)-1,3,4-oxadiazol-2-yl)imidazo[1,2-a]pyridin-6-yl)pyridin-3-yl)benzenesulfonamide](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/D/6/D608737.png)

![2,6-dichloro-4-[2-methyl-1-(1-methylpiperidin-4-yl)imidazo[4,5-c]quinolin-8-yl]phenol](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/D/6/D609463.png)

![2,3-di(thiophen-2-yl)benzo[g]quinoxaline-8-carboxylic acid](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/D/6/D608705.png)
危险品化学品经营许可证(带存储)